$ENLV just reported impressive earnings: $1.23B in net profit with $25.48 EPS.
A notable leap, reflecting strength in both Allocetra immunotherapy progress and its treasury strategy.
Now the key question is how the market prices this momentum in the near term.
@Enlivex 👀
From X
Disclaimer: The above content reflects only the author's opinion and does not represent any stance of CoinNX, nor does it constitute any investment advice related to CoinNX.